Healthcare Industry News: Baxano
News Release - August 14, 2014
Aurora Spine Appoints Regional Vice President of SalesCARLSBAD, CALIFORNIA--(Healthcare Sales & Marketing Network) - Aurora Spine Corporation (TSX VENTURE:ASG) announced today the appointment of Joe Bocchino as Regional Vice President of Sales for the Western United States. Mr. Bocchino will be responsible for Aurora's Western United States sales efforts. Under Mr. Bocchino's leadership, the Aurora sales team expects to strengthen its presence in the U.S. West Coast market.
Prior to joining Aurora Spine, Mr. Bocchino was Vice President of Sales - Western U.S. for Baxano Surgical where he was responsible for stabilizing product sales, relationships and merging the direct and distribution sales teams from Baxano and Trans1 following the acquisition of Baxano in March 2013.
Trent J. Northcutt, President and Chief Executive Officer, said, "Joe Bocchino's experience as a medical sales executive, with a proven track record to create and lead successful and dynamic sales teams, will be a tremendous asset to Aurora Spine. We believe his background and extensive knowledge of the spine industry will allow him to seamlessly integrate into this new role. Joe will focus on strengthening our Western sales and distribution network as we continue to make rapid progress on the creation of a hybrid sales force consisting of direct sales employees and independent distributors. I am confident that Joe will lead our sales team to maximum performance in 2014 and beyond".
About Aurora Spine
Aurora Spine is an early stage company focused on bringing new solutions to the spinal implant market through a series of innovative, minimally invasive, regenerative spinal implant technologies.
This news release contains forward-looking information that involves substantial known and unknown risks and uncertainties, most of which are beyond the control of Aurora Spine, including, without limitation, those listed under "Risk Factors" and "Cautionary Statement Regarding Forward-Looking Information" in Aurora Spine's final prospectus (collectively, "forward-looking information"). Forward-looking information in this news release includes information concerning Aurora Spine's proposed marketing efforts. Aurora Spine cautions investors of its securities about important factors that could cause Aurora Spine's actual results to differ materially from those projected in any forward-looking statements included in this news release. Any statements that express, or involve discussions as to, expectations, beliefs, plans, objectives, assumptions or future events or performance are not historical facts and may be forward-looking and may involve estimates, assumptions and uncertainties which could cause actual results or outcomes to differ unilaterally from those expressed in such forward-looking statements. No assurance can be given that the expectations set out herein will prove to be correct and, accordingly, prospective investors should not place undue reliance on these forward looking statements. These statements speak only as of the date of this press release and Aurora Spine does not assume any obligation to update or revise them to reflect new events or circumstances.
Source: Aurora Spine
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.